Gene content    
DLEC1 ( by HUGO)
Deleted In Lung And Esophageal Cancer 1
Tumor suppressor gene
Deleted In Lung And Esophageal Cancer 1
DLC1
DLC-1
F56
Deleted In Lung And Esophageal Cancer 1 Transcript Varient 2
Deleted In Lung And Esophageal Cancer Protein 1
Deleted In Lung Cancer Protein 1
NCBI: 3p21.3    Ensembl: 3p22.2
DLEC1_HUMANSize: 1755 amino acidsMass: 195684 Da

  • Tissue specificity: Expressed in all tissues examined. Expression is highest in prostate and testis [IMAGE] Custom PCR Arrays for DLEC1 Primer Products: [IMAGE] OriGene qSTAR qPCR primer pairs in human, mouse for DLEC1 [IMAGE] Pre-validated RT2 qPCR Primer Assay in human, mo
  • Function:
    UniProtKB/Swiss-Prot Summary: DLEC1_HUMAN, Q9Y238 Function: May act as a tumor suppressor by inhibiting cell proliferation
  • Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process negative regulation of cell proliferation TAS GOA 10213508

    Disorder & Mutation    
    Source Disease
    SWISS-PROTLung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The disease is caused by mutations affecting the gene represented in this entry. DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of lung cancer
    SWISS-PROTNote=DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of different cancers, including esophageal (ESCR), renal and lung cancers (LNCR)
    SWISS-PROTEsophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. Note=The disease is caused by mutations affecting the gene represented in this entry. DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of esophageal cancer

    DLEC1 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene